These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9704363)

  • 21. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research.
    Buell U; Cremerius U; Zimny M
    Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468
    [No Abstract]   [Full Text] [Related]  

  • 24. PET imaging I.
    Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):xi-xiii. PubMed ID: 15488552
    [No Abstract]   [Full Text] [Related]  

  • 25. Position emission tomography at the turn of the century: a perspective.
    Wagner HN
    Semin Nucl Med; 1992 Oct; 22(4):285-8. PubMed ID: 1439873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melorheostosis bone scintigraphy and F-18 fluorodeoxyglucose positron emission tomography.
    Kloos RT; Shreve P; Fig L
    Clin Nucl Med; 1996 Oct; 21(10):805-6. PubMed ID: 8896934
    [No Abstract]   [Full Text] [Related]  

  • 27. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 28. Positron emission tomography in oncology: the most sophisticated imaging technology.
    Lacić M; Maisey MN; Kusić Z
    Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin.
    Blockmans D; Knockaert D; Maes A; De Caestecker J; Stroobants S; Bobbaers H; Mortelmans L
    Clin Infect Dis; 2001 Jan; 32(2):191-6. PubMed ID: 11170907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PET in Aarhus: the origins of a laboratory].
    Gjedde A
    Dan Medicinhist Arbog; 2006; 34():156-78. PubMed ID: 17526157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified calculation of MRglc using PET.
    Phillips RL; London ED
    J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiopharmaceuticals for positron emission tomography. Development of new, innovative tracers for measuring the rates of physiologic and biochemical processes.
    Gatley SJ; DeGrado TR; Kornguth ML; Holden JE
    Acta Radiol Suppl; 1990; 374():7-11. PubMed ID: 1966972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in processes for PET radiotracer synthesis: separation of [¹⁸F]fluoride from enriched [¹⁸O]water.
    He P; Haswell SJ; Pamme N; Archibald SJ
    Appl Radiat Isot; 2014 Sep; 91():64-70. PubMed ID: 24907685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebral positron emission tomography with F18-fluorodeoxyglucose].
    Grupo PET de la SEMN.
    Rev Esp Med Nucl; 2002 Feb; 21(1):38-40. PubMed ID: 11821002
    [No Abstract]   [Full Text] [Related]  

  • 36. The heritage of radiotracers for positron emission tomography.
    Fowler JS; Wolf AP
    Acta Radiol Suppl; 1990; 374():13-6. PubMed ID: 1966960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical role of positron emission tomography in oncology.
    Bomanji JB; Costa DC; Ell PJ
    Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A real-time positron monitor for the estimation of stack effluent releases from PET medical cyclotron facilities.
    Mukherjee B
    Appl Radiat Isot; 2002 Dec; 57(6):899-905. PubMed ID: 12406635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical PET: are we ready?
    Coleman RE; Tesar RD
    J Nucl Med; 1997 Dec; 38(12):16N, 24N. PubMed ID: 9430451
    [No Abstract]   [Full Text] [Related]  

  • 40. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.